About G I Biotech Private Limited
Data last updated:
G I Biotech Private Limited was a private limited company based in Thane, Maharashtra, India, operated as a subsidiary of Dvk Investments Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the real estate financing segment of the financial services sector. It was incorporated on 25 August 2004.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC148220.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Krishna Datla Vasantkumar and Satish Varma Azad Nadimpally.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at A – 1501 Thane One Dil Complex Ghodbunder Road Majiwade, Maharashtra, India – 400610.
As per the financials filed for FY 2022, the company reported a revenue of ₹10,000, a decline of 75% compared to the previous year. For the same year it recorded a net loss of ₹41,011 (net margin -410.1%) and EBITDA of ₹9,292 (EBITDA margin 92.9%). Revenue has declined at a compounded annual rate (CAGR) of 75% over three years.
The last known website on record is fermentabiotech.com.
Company details
Contact details
G I Biotech Private Limited's registered office is in Thane, Maharashtra. Its website is fermentabiotech.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressA – 1501 Thane One Dil Complex Ghodbunder Road Majiwade, Maharashtra, India – 400610
- IndustryFinancial Services, Real Estate Financing
To see the full contact details of G I Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of G I Biotech Private Limited
FY 2022 filings availableG I Biotech Private Limited reported revenue of ₹10,000 (down 75% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 75% over three years, including a 75% fall in the latest year. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹10,000 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9,292 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹41,011 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 92.9% | ||||
| Net Profit Margin | -410.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of G I Biotech Private Limited, buy the company report.
Board of directors of G I Biotech Private Limited
G I Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Datla Vasantkumar Also directs: Fermenta Biotech Limited | Director | 27 Oct 2005 | 21 Years 0 Months | As last reported |
| Satish Varma Azad Nadimpally Also directs: Fermenta Biotech Limited | Director | 25 Aug 2004 | 22 Years 2 Months | As last reported |
Peer comparison
G I Biotech Private Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Medical Consumables, Real Estate Leasing), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| G I Biotech Private Limitedthis company | ₹10,000 (FY 2022) | -₹41,011 | -410.1% | -75.0% | Thane, Maharashtra, India | |
| Starshine Infradevelopers Private Limited | ₹10,000 (FY 2024) | Jaipur, Rajasthan, India | ||||
| Allured Infracity Private Limited | ₹10,000 (FY 2024) | Lucknow, Uttar Pradesh, India | ||||
| BG Infrashelters Private Limited | ₹10,000 (FY 2025) | -60.0% | Mumbai, Maharashtra, India | |||
| Maruti Nandan Devcon Private Limited | ₹10,000 (FY 2025) | 18.0% | Gwalior, Madhya Pradesh, India | |||
| Naman Projects Private Limited | ₹10,000 (FY 2025) | -17.0% | New Delhi, Delhi, India | |||
| Asta Buildwell Private Limited | ₹9,972 (FY 2025) | -98.0% | New Delhi, Delhi, India | |||
| Unicorn Organics Private Limited | ₹9,905 (FY 2025) | -89.0% | Telangana, India | |||
| Sivakasi Aruna Speciality Hospitals Private Limited | ₹9,833 (FY 2025) | -98.0% | Sivakasi, Tamil Nadu, India | |||
| R.K. Restaurant & Food Services Private Limited. | ₹9,800 (FY 2025) | 1.0% | Durg, Chhattisgarh, India | |||
| Novelty Stores Private Limited | ₹9,670 (FY 2022) | -13.0% | Kolkata, West Bengal, India |
To see the full peer comparison of G I Biotech Private Limited, buy the company report.
Auditor
G I Biotech Private Limited is audited by ANIL A DIKSHIT & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANIL A DIKSHIT & CO | FY 2021 | 100410W |
Shareholding
The shareholding of G I Biotech Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of G I Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving G I Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for G I Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for G I Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
G I Biotech Private Limited has 4 board changes on record since 2004: 2 appointments and 2 cessations. The latest: Irfan Rafik Bandukwalla ceased to be Director on 22 Jan 2010.
News
Frequently asked questions
G I Biotech has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
G I Biotech was a private limited company based in Thane, Maharashtra, India. The company worked in real estate financing, within the financial services industry. It was incorporated on 25 August 2004 and is registered under CIN U24230MH2004PTC148220. The company has been struck off by the Registrar of Companies and is no longer operational.
G I Biotech had 2 directors:
- Krishna Datla Vasantkumar - Director
- Satish Varma Azad Nadimpally - Director
The CIN (Corporate Identification Number) of G I Biotech is U24230MH2004PTC148220. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of G I Biotech is at A – 1501 Thane One Dil Complex Ghodbunder Road Majiwade, Maharashtra, India – 400610.
G I Biotech was incorporated on 25 August 2004. It is registered with the Registrar of Companies, Mumbai.
G I Biotech can be reached through the website fermentabiotech.com. Its registered office is in Thane, Maharashtra, India.
The latest financial statements of G I Biotech on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
G I Biotech operated in the financial services industry, in the real estate financing segment. It worked in this industry before it was struck off.
The peers of G I Biotech by revenue are Starshine Infradevelopers Private Limited, Allured Infracity Private Limited, BG Infrashelters Private Limited, Maruti Nandan Devcon Private Limited, Naman Projects Private Limited and 5 more, all in the BFSI industry (Medical Consumables, Real Estate Leasing).
Irfan Rafik Bandukwalla ceased to be Director on 22 Jan 2010. Sumanta Tarashankar Banerjee ceased to be Director on 27 Jan 2009. Krishna Datla Vasantkumar was appointed as Director on 27 Oct 2005. G I Biotech has 4 board changes on record in total.